CD47 and cardiovascular disorder: In the field of cardiovascular diseases, Chuang et al. [44] developed anti-CD47 CAR-Ms and found that CAR-Ms exhibited significantly enhanced phagocytic activity equivalent to that of CD47 antibody blockade.